Hayashi Motohiro, Chernov Mikhail F, Taira Takaomi, Ochiai Taku, Nakaya Kotaro, Tamura Noriko, Goto Shinichi, Yomo Shoji, Kouyama Nobuo, Katayama Yoko, Kawakami Yoriko, Izawa Masahiro, Muragaki Yoshihiro, Nakamura Ryoichi, Iseki Hiroshi, Hori Tomokatsu, Takakura Kintomo
Department of Neurosurgery, Neurological Institute, Tokyo Women's Medical University, Tokyo, Japan.
Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):852-7. doi: 10.1016/j.ijrobp.2007.04.043. Epub 2007 Jun 14.
To evaluate outcomes after pituitary radiosurgery in patients with post-stroke thalamic pain syndrome.
From 2002 to 2006, 24 patients with thalamic pain syndrome underwent pituitary radiosurgery at Tokyo Women's Medical University and were followed at least 12 months thereafter. The radiosurgical target was defined as the pituitary gland and its connection with the pituitary stalk. The maximum dose varied from 140 to 180 Gy. Mean follow-up after treatment was 35 months (range, 12-48 months).
Initial pain reduction, usually within 48 h after radiosurgery, was marked in 17 patients (71%). However, in the majority of cases the pain recurred within 6 months after treatment, and at the time of the last follow-up examination durable pain control was marked in only 5 patients (21%). Ten patients (42%) had treatment-associated side effects. Anterior pituitary abnormalities were marked in 8 cases and required hormonal replacement therapy in 3; transient diabetes insipidus was observed in 2 cases, transient hyponatremia in 1, and clinical deterioration due to increase of the numbness severity despite significant reduction of pain was seen once.
Pituitary radiosurgery for thalamic pain results in a high rate of initial efficacy and is accompanied by acceptable morbidity. It can be used as a primary minimally invasive management option for patients with post-stroke thalamic pain resistant to medical therapy. However, in the majority of cases pain recurrence occurs within 1 year after treatment.
评估垂体放射外科手术治疗中风后丘脑痛综合征患者的疗效。
2002年至2006年,24例丘脑痛综合征患者在东京女子医科大学接受垂体放射外科手术,并在术后至少随访12个月。放射外科手术靶点定义为垂体及其与垂体柄的连接部。最大剂量为140至180 Gy。治疗后平均随访35个月(范围12 - 48个月)。
17例患者(71%)在放射外科手术后48小时内疼痛明显减轻。然而,大多数病例在治疗后6个月内疼痛复发,在最后一次随访时,只有5例患者(21%)疼痛得到持久控制。10例患者(42%)出现与治疗相关的副作用。8例出现垂体前叶功能异常,3例需要激素替代治疗;2例出现短暂性尿崩症,1例出现短暂性低钠血症,1例尽管疼痛明显减轻但因麻木加重导致临床病情恶化。
垂体放射外科手术治疗丘脑痛的初始有效率较高,且发病率可接受。对于药物治疗无效的中风后丘脑痛患者,它可作为一种主要的微创治疗选择。然而,大多数病例在治疗后1年内疼痛复发。